![]() |
市場調查報告書
商品編碼
1359943
全球多菌株益生菌市場 - 2023-2030Global Multistrain Probiotics Market - 2023-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2022年,全球多菌株益生菌市場達到730億美元,預計2030年將達到1,371億美元,2023-2030年預測期間複合年成長率為8.2%。
多菌株益生菌中存在多種細菌菌株。經常食用可以使腸道保持健康狀態。由於它是一種安全產品,可以針對疾病和傳染源提供治療和保護屏障,因此多菌株益生菌的使用越來越受歡迎。由於不同菌株之間的協同作用和累加效應,多菌株益生菌也比單菌株益生菌更健康。
多菌株益生菌市場可能在未來幾年保持成長勢頭,因為它們具有更廣泛的功效和協同效應。此外,由於人們越來越了解多菌株益生菌對免疫、消化系統和整體健康的影響,因此對多菌株益生菌的需求不斷增加。領先的益生菌製造商正在利用消費者可支配收入的增加和飲食意識的提高,努力提高其各種多菌株益生菌的銷售利潤。
亞太地區主導全球多菌株益生菌市場,2022 年收入佔有率為 46.5%。亞太地區多菌株益生菌市場受到不斷成長的消費者需求、媒體關注和新技術意識的推動。中國和印度益生菌意識的不斷增強預計將加速該地區市場的成長。
隨著消費者腸道健康意識的增強,對多菌株益生菌的需求預計將會增加。隨著保持健康的腸道對消費者變得越來越重要,近年來,主要參與者積極提供益生菌食品、飲料和補充劑。隨著越來越多的消費者接受腸道健康與身體健康、體重管理和能量維持之間的聯繫,預計未來幾年益生菌的需求將會增加。健康飲食趨勢的興起以及人們對營養對健康影響的認知不斷增強,促使製造商生產和銷售具有特定健康聲明的食品。西方市場的消費者對健康生活採取全面的態度,益生菌的消費量正在增加。
為了向消費者提供高品質的益生菌產品,製造商正在嘗試添加免疫益處的益生菌的配方和生產。多菌株配方、菌株特異性製劑等方面的工作正在進行中。例如,益生菌飲料和補充劑公司 GoodBellyProbiotics 於 2022 年 8 月推出了新的免疫支持產品線,其中包括誇脫飲料和注射。 GoodBellyImmune Support Shots 的鳳梨、百香果、檸檬、生薑和薑黃口味含有與誇脫相同的益生菌菌株。
多菌株益生菌對人類和動物的健康優勢在全球範圍內得到認可。世界衛生組織、IPA 以及國際益生菌和益生元科學協會等國際組織正在提高人們對益生菌的認知,因為益生菌的益處越來越多。益生菌研發的監管和投資政策由協會與各國政府合作制定,推動了多菌株益生菌市場的發展。此外,益生菌研究也取得了重大進展,提高了人們對各種菌株的作用及其潛在健康優勢的了解。益生菌產業越來越有興趣利用科學進步來創造具有特定特徵和功能的菌株。
多菌株益生菌市場的發展受到研發活動、實驗室、研究設備的大量投資以及僱用合格員工的高成本的阻礙。益生菌菌株和產品的開發和生產遵循國際食品法規。由於生產成本高,所以成品價格也高。不同的分銷管道用於行銷和分銷益生菌產品。它們也有各種包裝。因此,這些因素提高了產品的成本,使其變得更加昂貴,進而抑制了消費者的購買行為,為產業參與者帶來了挑戰。
Global Multistrain Probiotics Market reached US$ 73 billion in 2022 and is expected to reach US$ 137.1 billion by 2030, growing with a CAGR of 8.2% during the forecast period 2023-2030.
Multiple bacterial strains are present in multistrain probiotics. Regular consumption keeps the gut in a healthy state. Because it is a safe product that provides a therapeutic and protective barrier against diseases and infectious agents, the use of multistrain probiotics is growing in popularity. Due to the synergy and additive effects between the various isolates, multistrain probiotics are also significantly healthier than single-strain probiotics.
The market for multistrain probiotics is likely to maintain its momentum in the coming years because they suggest a wider spectrum of efficacy and synergistic effects. In addition, there is a rising need for multistrain probiotics due to growing knowledge about their effects on immunity, the digestive system, and overall wellness. Leading probiotics manufacturers are working to increase the profitability of sales of their wide range of multistrain probiotics by taking advantage of consumers' rising disposable income and increasing dietary awareness.
Asia Pacific dominated the global multistrain probiotics market with revenue share of 46.5% in the year 2022. The Asia-Pacific multistrain probiotics market is driven by rising consumer demand, media attention, and awareness of new technology. Growing probiotic awareness in China and India is anticipated to accelerate the growth of the regional market.
The demand for multistrain probiotics is anticipated to increase as consumer awareness of gut health increases. As maintaining a healthy gut becomes more crucial to consumers, major players have actively offered probiotic food, drinks, and supplements in recent years. Probiotic demand is anticipated to rise in the coming years as more consumers accept the connection between gut health and physical health, weight management, and energy maintenance. The production and marketing of food with specific health claims by manufacturers is prompted by rising trends towards healthier diets and growing awareness of the impact of nutrition on health. Western markets, where consumers adopt a holistic approach to healthy living, are seeing an increase in probiotic consumption.
To provide consumers with high-quality probiotic products, manufacturers are experimenting with the formulation and production of probiotics with the added immunity benefits. Work is being done on multi-strain formulations, strain-specific formations, etc. For instance, the probiotic beverage and supplement company GoodBellyProbiotics unveiled its new Immune Support product line in August 2022, which includes quart beverages and shots. The pineapple, passionfruit, lemon, ginger, and turmeric flavours of the GoodBellyImmune Support Shots contain the same probiotic strains that the quarts do.
The health advantages of multistrain probiotics for both humans and animals are acknowledged on a global scale. International organisations like the WHO, IPA, and the International Scientific Association for Probiotics and Prebiotics are raising awareness about probiotics due to their growing benefits. The regulation and investment policies for probiotic R&D are drafted by associations in collaboration with national governments, which in turn drives the multistrain probiotics market. Additionally, there have been significant advancements in probiotic research, which have improved the understanding of the workings of various strains and their potential health advantages. The probiotic industry is increasingly interested in using scientific advancements to create strains with particular characteristics and capabilities.
The development of the multistrain probiotics market is hindered by significant investments in R&D activities, laboratories, research equipment, and the high cost of hiring qualified employees. International food regulations are followed in the development and production of probiotic strains and products. Due to the high cost of production, the price of the finished product is high. Different channels of distribution are used for marketing and distributing probiotic products. They come in various packaging as well. Thus, these factors raise the cost of the product, making it more expensive, which in turn restrains consumer purchasing behaviour and presents a challenge for industry players.
The global multistrain probiotics market is segmented based on application, end-user and region.
The segment is anticipated to grow as a result of rising consumer demand for food products with higher nutrient and fibre contents. Probiotics and other digestive ingredients are frequently used in fish oil and yoghurt to lower the risk of issues with gut health. Probiotics have become more popular among consumers as a remedy for their health problems as a result of rising disposable incomes and a growing awareness of ways to improve quality of life. Due to the rising demand for probiotics in foods and drinks, manufacturers are growing their operations. For instance, Korea's Hy Co, formerly known as Korea Yakult, announced in August 2022 that it would be expanding into probiotic business categories to offer a wider range of products.
Due to growing awareness of fitness and maintaining good digestive health, consumers in this region are becoming more and more interested in healthy products. In addition, there is a growing market for products that support a healthy gut microbiome due to the growing significance of gut health in overall wellbeing. Multistrain probiotic supplements are becoming more and more well-liked among the region's health-conscious consumers because they are thought to be an easy and efficient way to add beneficial bacteria to the gut. The demand for multistrain probiotics in infant formula has been extremely high in China and is expected to continue to rise over the next few years. Due to an ageing population, a growing awareness of the value of preventive healthcare, and numerous studies demonstrating the advantages of these products for immunity, cognitive health, and skincare, the market in Asia Pacific has experienced significant growth.
The COVID-19 pandemic has increased understanding of the value of a robust immune system. To support their immune systems, many consumers have turned to dietary supplements, such as multistrain probiotics. The marketing of some multistrain probiotics as immune-boosters has increased demand. Furthermore, the significance of overall health and wellness has been emphasised by COVID-19. Customers are more likely to spend money on products that support overall health, which includes gut health. Multistrain probiotics have benefited from this development because of their potential to support immune and digestive health.
Supply chains were disrupted by geopolitical tensions and economic sanctions, which had an impact on where raw materials were sourced and how multistrain probiotics were produced. Supply issues result from suppliers or manufacturers being situated in regions that are directly impacted by the conflict. Additionally, the economic unpredictability brought on by the war caused some consumers to cut back on discretionary spending, including on dietary supplements. The sales of multistrain probiotics were impacted by this.
The major global players in the market: Yakult Honsha Co., Ltd., Deerland Enzymes, Inc., Protexin, Danisco, BioGaia, Chr. Hansen, Daflorn Ltd., Lallemand Inc., Probi AB and Innovix Labs.
The global multistrain probiotics market report would provide approximately 53 tables, 46 figures and 186 Pages.